Hikma Launches First Once-Daily Generic Victoza In The US
As The Firm Celebrated Several Other Generic Drug Launches In The American Market
The FDA delivered its “Christmas gift” of approving Hikma’s generic Victoza, the first once-daily liraglutide injectable on the US market.
